4//SEC Filing
Eckburg Paul 4
Accession 0001610717-24-000165
CIK 0001880438other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:27 PM ET
Size
7.0 KB
Accession
0001610717-24-000165
Insider Transaction Report
Form 4
Eckburg Paul
Chief Medical Officer
Transactions
- Award
Common
2024-03-15+30,000→ 51,416 total - Award
Stock Option (right to buy)
2024-03-15+60,000→ 60,000 totalExercise: $3.00Exp: 2034-03-14→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]These restricted stock units vest as follows: 1/16th of the shares vests quarterly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
- [F2]Reflects the adjusted total which includes the purchase of 3,127 shares under the AN2 Therapeutics, Inc. 2022 Employee Stock Purchase Plan on March 31, 2023.
- [F3]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914512
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 7:27 PM ET
- Size
- 7.0 KB